OncoMatch/Clinical Trials/NCT05772390
Partial Breast Re-irradiation in Women in Women with Locally Recurrent Breast Cancer Previously Treated with Conservative Surgery and Whole Breast Irradiation
Is NCT05772390 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies non-drug interventions for breast cancer.
A prospective study of partial breast re-irradiation in patients with local recurrence of breast cancer
Check if I qualifyExtracted eligibility criteria
Cancer type
Breast Carcinoma
Biomarker criteria
Excluded: BRCA1 pathogenic mutation
Excluded: BRCA2 pathogenic mutation
Excluded: TP53 pathogenic mutation
Performance status
ECOG 0–1(Restricted strenuous activity)
Prior therapy
Must have received: breast conserving therapy (surgery and whole breast radiotherapy)
≥ 24 months interval between initial breast conserving therapy (surgery and whole breast radiotherapy) and recurrence
Cannot have received: IORT, brachytherapy or previous partial breast treatment
Previous breast RT performed with IORT, brachytherapy or previous partial breast treatment
Cannot have received: chemotherapy
Exception: within 2 weeks prior to study RT
Patients who had chemotherapy within 2 weeks prior to study RT
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify